Cogent Biosciences, Inc.
COGT
$37.93
$0.621.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 31.83M | 28.24M | 23.93M | 14.37M | 13.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 102.64M | 103.61M | 99.49M | 83.36M | 75.58M |
| Operating Income | -102.64M | -103.61M | -99.49M | -83.36M | -75.58M |
| Income Before Tax | -96.41M | -97.35M | -102.49M | -80.93M | -73.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -96.41M | -97.35M | -102.49M | -80.93M | -73.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.41M | -97.35M | -102.49M | -80.93M | -73.53M |
| EBIT | -102.64M | -103.61M | -99.49M | -83.36M | -75.58M |
| EBITDA | -101.90M | -102.98M | -98.87M | -82.71M | -74.93M |
| EPS Basic | -0.56 | -0.60 | -0.68 | -0.59 | -0.64 |
| Normalized Basic EPS | -0.35 | -0.38 | -0.39 | -0.37 | -0.40 |
| EPS Diluted | -0.56 | -0.60 | -0.68 | -0.59 | -0.64 |
| Normalized Diluted EPS | -0.35 | -0.38 | -0.39 | -0.37 | -0.40 |
| Average Basic Shares Outstanding | 171.05M | 162.27M | 150.08M | 137.62M | 114.54M |
| Average Diluted Shares Outstanding | 171.05M | 162.27M | 150.08M | 137.62M | 114.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |